The U.S. Food and Drug Administration recently approved a prosthetic eye implant developed by Professor Mark Humayun, which represents the first treatment to restore limited vision to blind patients. This device, known as the Argus II, uses electrodes implanted in the eye to transmit images to the brain, bypassing retinas damaged by retinitis pigmentosa. This technology might eventually treat conditions other than blindness, such as spinal paralysis….Continue Reading Argus II, now FDA approved, brings sight to the blind